BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 23218039)

  • 1. [Surveillance for Barrett's oesophagus: worthwhile?].
    Kastelein F; Kuipers EJ
    Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should patients with Barrett's oesophagus be kept under surveillance? The case against.
    Barritt AS; Shaheen NJ
    Best Pract Res Clin Gastroenterol; 2008; 22(4):741-50. PubMed ID: 18656827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale for screening and surveillance of Barrett's metaplasia.
    Wani S; Sharma P
    Best Pract Res Clin Gastroenterol; 2006; 20(5):829-42. PubMed ID: 16997164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Revision needed of follow-up policy for Barrett's esophagus].
    Giard RW; Coebergh JW; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the endoscopic surveillance of Barrett's oesophagus.
    Bergman JJ; Tytgat GN
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i38-42. PubMed ID: 15711007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
    Mayne GC; Bright T; Hussey DJ; Watson DI
    ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.
    Inadomi JM
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):51-63. PubMed ID: 25743456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
    Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
    Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
    Peters FT; Kleibeuker JH
    Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to get the most out of costly Barrett's oesophagus surveillance.
    Braden B; Jones-Morris E
    Dig Liver Dis; 2018 Sep; 50(9):871-877. PubMed ID: 29730158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and surveillance of Barrett's esophagus.
    Regula J
    Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.